Sargassum horneri Extract Ameliorates DSS-Induced Colitis through Modulation of mTOR Axis and Intestinal Microbiota

Abstract

Ulcerative colitis is a chronic inflammatory bowel disease characterized by colonic mucosal inflammation, intestinal microflora imbalance, and intestinal permeability. It is essential to develop natural compounds with anti-inflammatory and intestinal bacterial imbalance correction properties. The brown alga Sargassum horneri is rich in polyphenols, such as fucoxanthin and chromene, which have antioxidant, anti-inflammatory, and anti-cancer properties. In results, S. horneri ethanol extract (SHE) reduced TNF-α and IL-6 levels as well as Pi3k/Mtor/S6k mRNA expression in LPS-treated RAW264.7 and Caco-2 cells. In addition, SHE treatment decreased the expression of genes associated with inflammation and the mTOR axis in the co-culture system while increasing the expression of tight junction factors. In a mouse model of dextran sulfate sodium (DSS)-induced colitis, SHE treatment improved intestinal length, histological scores, and the expression of genes related to tight junctions while decreasing the expression of genes related to inflammatory markers and the mTOR axis. The gut microbiota of mice treated with SHE exhibited a decrease in the ratio of Firmicutes to Bacteroidota, which had been increased by DSS treatment and an increase in beneficial bacteria. Therefore, SHE consumption may be a useful natural alternative, as it improves gut microbiota, alleviates colitis symptoms, and prevents their onset.